New therapeutic approaches for neurological diseases

Hermo Pharma Ltd. is a biopharmaceutical company focused on discovering and developing novel treatments for severe neurological diseases. Our research focus is on neurodegenerative diseases and on modulation of neuronal plasticity. Hermo Pharma Ltd. aims at developing novel disease-modifying treatments for amblyopia, Parkinson’s disease and Alzheimer’s disease.